个人简介
Mark Vickers graduated from Oxford University in 1983, having completed his preclinical studies at Cambridge with a Biochemistry Part II. After general medical jobs in London, Dr Vickers took up an MRC Training Fellowship at the Institute of Molecular Medicine in Oxford, working with Doug Higgs on genes surrounding the alpha-globin gene cluster. He then trained in Haematology at the Hammersmith, Reading and John Radcliffe Hospitals from (1990–1996). He took up his current post as Senior Lecturer at Aberdeen in 1996 and was promoted to Professor in the section of Applied Medicine in 2008. He took up directorship of the Academic Transfusion Medicine Unit in 2010.
研究领域
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
My main current interest is in how cells are recognised as being damaged by macrophages, using red blood cells as the main model system. This work impinges on both congential and acquired anaemias as well as the use of macrophages for therapeutic purposes. I also have interests in cellular immune responses to Epstein-Barr virus (EBV) and lymphomas. Work on EBV encompasses the epidemiology of IM, meta-analyses of the associations between viral infection and immune mediated diseases and laboratory analyses of CD4 responses to the virus. I am the clinical lead for a Wellcome Trust funded anti-EBV cytotoxic lymphocyte bank used to treat EBV driven lymphomas.
京公网安备 11010802027423号